CDK8-IN-9
Product Specifications
Target
Others, CDK
Related Pathways
Cell Cycle/Checkpoint, Others
Bioactivity
CDK8-IN-9 (compound 22) is a potent type II CDK8 inhibitor (IC50: 48.6 nM) with demonstrated inhibitory effects on tumor growth, making it a valuable tool for studying colorectal cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6302531-01 0.1 mL
GLG1, CT (GLG1, CFR1, ESL1, MG160, Golgi apparatus protein 1, CFR-1, Cysteine-rich fibroblast growth factor receptor, E-selectin ligand 1, Golgi sialoglycoprotein MG-160) (MaxLight 650)
Sign In for Pricing
View Details MBS6302531-02 5x 0.1 mL
GLG1, CT (GLG1, CFR1, ESL1, MG160, Golgi apparatus protein 1, CFR-1, Cysteine-rich fibroblast growth factor receptor, E-selectin ligand 1, Golgi sialoglycoprotein MG-160) (MaxLight 650)
Sign In for Pricing
View Details 
T9156-40L 100 µg
Tubulin, gamma (TUBG, Tubulin gamma 1 Chain, TUBG1, Tubulin gamma 2 Chain, TUBG2, Gamma 1 Tubulin, Gamma 2 Tubulin, Gamma Tubulin 1, Gamma Tubulin 2, Gamma Tubulin Complex Component 1, GCP 1, GCP-1, MGC131994, Xgam)
Sign In for Pricing
View Details 